Activated protein C in a pregnant patient with severe sepsis
Mahabeer, N.; Zwaal, J.
Hospital Medicine 66(2): 124
2005
ISSN/ISBN: 1462-3935 PMID: 15739714 Document Number: 590383
Document emailed within 1 workday
Related Documents
Bartelink, A.K.M. 2006: Questionable efficacy and safety of activated drotrecogin alpha (activated protein C) in the treatment of severe sepsis Nederlands Tijdschrift Voor Geneeskunde 150(7): 352-354Liang, J.; Streat, S.; Torrance, J.; Sleigh, J.; Freebairn, R.; Ramsay, M. 2003: Drotrecogin alfa (recombinant human activated protein C) in severe sepsis--a New Zealand viewpoint New Zealand Medical Journal 116(1181): U586
Maglio, D. 2002: Drotrecogin alfa (activated) for severe sepsis Connecticut Medicine 66(3): 145-150
Macias, W.L.; Yan, S.B.; Grinnell, B.W. 2004: The development of drotrecogin alfa (activated) for the treatment of severe sepsis International Journal of Artificial Organs 27(5): 360-370
Lai, P.S.; Matteau, A.; Iddriss, A.; Hawes, J.C.L.; Ranieri, V.; Thompson, B.T. 2013: An updated meta-analysis to understand the variable efficacy of drotrecogin alfa (activated) in severe sepsis and septic shock Minerva Anestesiologica 79(1): 33-43
Ruangchan, S.; Chusri, S.; Saengsanga, P.; Kiamkan, N.; Phunpairoth, P.; Chayakul, P. 2016: Clinical Outcomes of Community-Acquired Severe Sepsis after Implementation of a Simple Severe Sepsis Fast Track Journal of the Medical Association of Thailand 99(8): 877-885
Brun-Buisson, C.; Doyon, F.; Carlet, J.; Dellamonica, P.; Gouin, F.; Lepoutre, A.; Mercier, J.C.; Offenstadt, G.; Régnier, B. 1995: Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. a multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis JAMA 274(12): 968-974
Uszyiński, W.; Uszyński, M.ła.; Lisiecki, A. 2005: Novel treatment for severe sepsis: recombinant human protein C (RHAPC) Ginekologia Polska 76(11): 913-920
Baratto, F.; Michielan, F.; Gagliardi, G.; Di Gregorio, G.; Pasqualetto, A.; Meroni, M.; Giron, G.P. 2004: Use of protein C concentrate in adult patients with severe sepsis and septic shock Minerva Anestesiologica 70(5): 351-356
Regéczy, N.; Lakos, G.; Balogh, I.; Kappelmayer, J.; Kiss, E. 2000: Membranous glomerulonephritis in a patient with inherited activated protein C resistance Clinical Nephrology 53(5): 390-393
Chang, T.M.; Espinosa-Meléndez, E.; Francoeur, T.E.; Eade, N.R. 1980: Albumin-collodion activated charcoal hemoperfusion in the treatment of severe theophylline intoxication in a 3-year-old patient Pediatrics 65(4): 811-814
Giordano, P.; Sabato, V.; Schettini, F.; De Mattia, D.; Iolascon, A. 1997: Resistance to activated protein C as a risk factor of stroke in a thalassemic patient Haematologica 82(6): 698-700
McMenamin, L.; Murch, N.; Daniels, R. 2013: Severe sepsis, social media and the #Sepsis 6: 'Tweeting' national innovations Acute Medicine 12(2): 83-88
Aikawa, N. 2011: Revised Surviving Sepsis Campaign Guidelines and therapy for severe sepsis Japanese Journal of Antibiotics 64(1): 37-44
Alarcón-Segovia, D.; Ruiz-Argüelles, G.J.; Garcés-Eisele, J.; Ruiz-Argüelles, A. 1996: Inherited activated protein C resistance in a patient with familial primary antiphospholipid syndrome Journal of Rheumatology 23(12): 2162-2165
Moore, C.C.; Jacob, S.T.; Pinkerton, R.; Meya, D.B.; Mayanja-Kizza, H.; Reynolds, S.J.; Scheld, W.Michael. 2008: Point-of-care lactate testing predicts mortality of severe sepsis in a predominantly HIV type 1-infected patient population in Uganda Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 46(2): 215-222
Kozłowska, I.; Krzystolik, A.; Rózański, J.; Nikodemska, I.; Kurowski, Mł.; Ciechanowski, K. 2005: Resistance to activated protein C in a patient with multiple myocardial infarctions and stroke--a case report Kardiologia Polska 62(2): 151-152
Wang, R.; Yang, Z.; Zhu, J.-m.; Wang, J.-l.; Yang, H.-x.; Wang, Q.; Zhai, G.-r.; Li, Z.; Yu, M. 2006: Screening for G1528C mutation in mitochondrial trifunctional protein gene in pregnant women with severe preeclampsia and new born infant Zhonghua Fu Chan Ke Za Zhi 41(10): 672-675
Kähler, C.M.; Högl, B.; Habeler, R.; Brezinka, C.; Hamacher, Jürg.; Dienstl, A.; Prior, C. 2002: Management of respiratory deterioration in a pregnant patient with severe kyphoscoliosis by non-invasive positive pressure ventilation Wiener Klinische Wochenschrift 114(19-20): 874-877
Van der Klooster, J.M.; Grootendorst, A.F. 2002: Capnocytophaga canimorsus sepsis in an immune-competent patient: tiny dog, major sepsis Netherlands Journal of Medicine 60(4): 186-7; author reply 188